{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:41:56Z","timestamp":1772264516567,"version":"3.50.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Vancomycin-resistant enterococci (VRE) represent a public health threat due to the few available treatments. Such alarm has triggered worldwide initiatives to develop effective antimicrobial compounds and novel delivery and therapeutic strategies. vanA operon is responsible for most cases of acquired vancomycin resistance in enterococci.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Development of a transcription factor decoy (TFD) system as a vanA gene transcription-inhibitor.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Vancomycin MIC was determined in the presence of TFD-lipoplexes. Additionally, the effect of TFD-lipoplexes on the expression level of the vanA gene and the growth pattern of E. faecalis was evaluated. The haemolytic activity of the developed TFD-lipoplexes and their cytotoxicity were examined. TFD-lipoplexes efficiency in treating vancomycin-resistant E. faecalis (VREF) infection was tested in vivo using a systemic mice infection model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A reduction in vancomycin MIC against VRE from 256\u2005mg\/L (resistant) to 16\u2005mg\/L (intermediate susceptible), in the presence of TFD-lipoplexes, was recorded. The developed TFD-lipoplexes lacked any effect on E. faecalis growth and significantly reduced the transcription level of the vanA gene by about 3-fold. In an initial evaluation of the safety of TFD-lipoplexes, they were found not to be overtly haemolytic to human blood or cytotoxic to human skin fibroblast cells. The co-administration of TFD-lipoplexes and vancomycin efficiently eradicated VREF infection in vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The developed TFD-lipoplexes successfully restored vancomycin activity against VREF. They offer a safe effective unconventional therapy against this stubborn organism and present a revolution in gene therapy that can be applied to other resistance-encoding genes in various organisms.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkae320","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:43:23Z","timestamp":1724798603000},"page":"2999-3006","source":"Crossref","is-referenced-by-count":1,"title":["Restoring vancomycin activity against resistant <i>Enterococcus faecalis<\/i> using a transcription factor decoy as a <i>vanA<\/i> operon-inhibitor"],"prefix":"10.1093","volume":"79","author":[{"given":"Loai M","family":"Abdelall","sequence":"first","affiliation":[{"name":"Department of General Administration of Factories Inspection, Central Administration of Operations, Egyptian Drug Authority , Giza 12654 ,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra Ibrahim","family":"Nagy","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University , Cairo 11562 ,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona T","family":"Kashef","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University , Cairo 11562 ,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"2024110323540060900_dkae320-B1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.idc.2021.07.002","article-title":"Vancomycin-resistant enterococci: epidemiology, infection prevention, and control","volume":"35","author":"Joshi","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"2024110323540060900_dkae320-B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/microorganisms11010024","article-title":"Vancomycin resistance in Enterococcus and Staphylococcus aureus","volume":"11","author":"Li","year":"2022","journal-title":"Microorganisms"},{"key":"2024110323540060900_dkae320-B3","volume-title":"COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report","author":"CDC","year":"2022"},{"key":"2024110323540060900_dkae320-B4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fmicb.2018.01441","article-title":"Nano-strategies to fight multidrug resistant bacteria\u2014'A battle of the titans\u2019","volume":"9","author":"Baptista","year":"2018","journal-title":"Front Microbiol"},{"key":"2024110323540060900_dkae320-B5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4103\/ijmr.IJMR_2554_19","article-title":"Genotypic characterization of vancomycin-resistant Enterococcus causing urinary tract infection in northern India","volume":"155","author":"Das","year":"2022","journal-title":"Indian J Med Res"},{"key":"2024110323540060900_dkae320-B6","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3390\/microorganisms9102026","article-title":"Regulation of resistance in vancomycin-resistant enterococci: the VanRS two-component system","volume":"9","author":"Guffey","year":"2021","journal-title":"Microorganisms"},{"key":"2024110323540060900_dkae320-B7","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.88389","volume-title":"Pathogenic Bacteria","author":"Delpech","year":"2019"},{"key":"2024110323540060900_dkae320-B8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2017.06.122","article-title":"Transcription factor decoy technology: A therapeutic update","volume":"144","author":"Hecker","year":"2017","journal-title":"J Biotechnol"},{"key":"2024110323540060900_dkae320-B9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/ph12020081","article-title":"Cardiolipin-based lipopolyplex platform for the delivery of diverse nucleic acids into Gram-negative bacteria","volume":"12","author":"Perche","year":"2019","journal-title":"Pharmaceutics"},{"key":"2024110323540060900_dkae320-B10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejpb.2018.11.017","article-title":"Solid lipid nanoparticles for the delivery of anti-microbial oligonucleotides","volume":"134","author":"Gonz\u00e1lez-Paredes","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"2024110323540060900_dkae320-B11","doi-asserted-by":"publisher","first-page":"41242","DOI":"10.1038\/srep41242","article-title":"Antimicrobial nanoplexes meet model bacterial membranes: the key role of Cardiolipin","volume":"7","author":"Mar\u00edn-Men\u00e9ndez","year":"2017","journal-title":"Sci Rep"},{"key":"2024110323540060900_dkae320-B12","doi-asserted-by":"publisher","first-page":"106762","DOI":"10.1016\/j.micpath.2024.106762","article-title":"Development of a transcription factor decoy-nanocarrier system as a successful inhibitor of Enterococcus faecalis virulence in vitro and in vivo","volume":"193","author":"Badr","year":"2024","journal-title":"Microb Pathog"},{"key":"2024110323540060900_dkae320-B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10123-024-00506-w","article-title":"Repurposing fusidic acid as an antimicrobial against enterococci with a low probability of resistance development","author":"Abdelmassih","year":"2024","journal-title":"Int Microbiol"},{"key":"2024110323540060900_dkae320-B14","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.3390\/diagnostics12112691","article-title":"Development of a multiplex polymerase chain reaction-based DNA lateral flow assay as a point-of-care diagnostic for fast and simultaneous detection of MRSA and vancomycin resistance in bacteremia","volume":"12","author":"Kashef","year":"2022","journal-title":"Diagnostics"},{"key":"2024110323540060900_dkae320-B15","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1021\/bi00181a024","article-title":"Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium","volume":"33","author":"Holman","year":"1994","journal-title":"Biochemistry"},{"key":"2024110323540060900_dkae320-B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.resp.2016.06.001","article-title":"Cationic liposomes containing antioxidants reduce pulmonary injury in experimental model of sepsis: liposomes antioxidants reduce pulmonary damage","volume":"231","author":"Galv\u00e3o","year":"2016","journal-title":"Respir Physiol Neurobiol"},{"key":"2024110323540060900_dkae320-B17","doi-asserted-by":"publisher","first-page":"e0220684","DOI":"10.1371\/journal.pone.0220684","article-title":"Co-delivery of free vancomycin and transcription factor decoy-nanostructured lipid carriers can enhance inhibition of methicillin resistant Staphylococcus aureus (MRSA)","volume":"14","author":"Hibbitts","year":"2019","journal-title":"PLoS One"},{"key":"2024110323540060900_dkae320-B18","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for bacteria That Grow Aerobically\u2014Eleventh Edition: M07","author":"CLSI","year":"2018"},{"key":"2024110323540060900_dkae320-B19","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing\u2014Thirty-First Edition: M100","author":"CLSI","year":"2021"},{"key":"2024110323540060900_dkae320-B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-021-02291-2","article-title":"Synergistic effects of silver ions and metformin against Enterococcus faecalis under high-glucose conditions in vitro","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Microbiol"},{"key":"2024110323540060900_dkae320-B21","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1128\/AAC.01737-09","article-title":"Specificity of induction of the vanA and vanB operons in vancomycin-resistant enterococci by telavancin","volume":"54","author":"Hill","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2024110323540060900_dkae320-B22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jmii.2014.09.003","article-title":"Comparison of vanA gene mRNA levels between vancomycin-resistant Enterococci presenting the VanA or VanB phenotype with identical Tn1546-like elements","volume":"49","author":"Shen","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"2024110323540060900_dkae320-B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-7-85","article-title":"Statistical analysis of real-time PCR data","volume":"7","author":"Yuan","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"2024110323540060900_dkae320-B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.toxlet.2018.04.008","article-title":"Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells","volume":"291","author":"Allam","year":"2018","journal-title":"Toxicol Lett"},{"key":"2024110323540060900_dkae320-B25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"2024110323540060900_dkae320-B26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijpharm.2014.09.045","article-title":"In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration","volume":"476","author":"Mahmoud","year":"2014","journal-title":"Int J Pharm"},{"key":"2024110323540060900_dkae320-B27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/jac\/dkf245","article-title":"The in vitro and in vivo antibacterial characterization of vancomycin and linezolid against vancomycin-susceptible and -resistant enterococci","volume":"50","author":"Miyazaki","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"2024110323540060900_dkae320-B28","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.2147\/IJN.S107107","article-title":"Novel antimicrobial peptide\u2013modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus","volume":"11","author":"Liu","year":"2016","journal-title":"Int J Nanomed"},{"key":"2024110323540060900_dkae320-B29","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.14202\/vetworld.2022.2407-2413","article-title":"Evolutionary conservation of motifs within vanA and vanB of vancomycin-resistant enterococci","volume":"15","author":"Memili","year":"2022","journal-title":"Vet World"},{"key":"2024110323540060900_dkae320-B30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/pharmaceutics13030428","article-title":"Delivery systems for nucleic acids and proteins: barriers, cell capture pathways and nanocarriers","volume":"13","author":"Torres-Vanegas","year":"2021","journal-title":"Pharmaceutics"},{"key":"2024110323540060900_dkae320-B31","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.bbamem.2017.06.006","article-title":"Cationic liposomal vectors incorporating a bolaamphiphile for oligonucleotide antimicrobials","volume":"1859","author":"Mamusa","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"2024110323540060900_dkae320-B32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1128\/AAC.45.3.973-975.2001","article-title":"Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer","volume":"45","author":"Torres-Viera","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2024110323540060900_dkae320-B33","doi-asserted-by":"publisher","first-page":"e85873","DOI":"10.1371\/journal.pone.0085873","article-title":"The role of the staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus","volume":"9","author":"Qureshi","year":"2014","journal-title":"PLoS One"},{"key":"2024110323540060900_dkae320-B34","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/jps.20627","article-title":"In vitro hemolysis: guidance for the pharmaceutical scientist","volume":"95","author":"Amin","year":"2006","journal-title":"J Pharm Sci"},{"key":"2024110323540060900_dkae320-B35","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1021\/nl0805615","article-title":"Method for analysis of nanoparticle hemolytic properties in vitro","volume":"8","author":"Dobrovolskaia","year":"2008","journal-title":"Nano Lett"},{"key":"2024110323540060900_dkae320-B36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/pharmaceutics13030427","article-title":"Biodistribution and pharmacokinetics of liposomes and exosomes in a mouse model of sepsis","volume":"13","author":"Mirzaaghasi","year":"2021","journal-title":"Pharmaceutics"},{"key":"2024110323540060900_dkae320-B37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2133\/dmpk.20.275","article-title":"Pharmacokinetic analysis of the tissue distribution of octaarginine-modified liposomes in mice","volume":"20","author":"Mudhakir","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"2024110323540060900_dkae320-B38","doi-asserted-by":"publisher","first-page":"2100639","DOI":"10.1002\/adhm.202100639","article-title":"Liposomes and extracellular vesicles as drug delivery systems: A comparison of composition, pharmacokinetics, and functionalization","volume":"11","author":"Van der Koog","year":"2022","journal-title":"Adv Healthc Mater"},{"key":"2024110323540060900_dkae320-B39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s42506-023-00133-9","article-title":"Prevalence of vancomycin-resistant enterococci (VRE) in Egypt (2010\u20132022): a systematic review and meta-analysis","volume":"98","author":"Azzam","year":"2023","journal-title":"J Egypt Public Health Assoc"},{"key":"2024110323540060900_dkae320-B40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1365-2958.2005.04706.x","article-title":"Binding sites of VanRB and \u03c370 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524","volume":"57","author":"Depardieu","year":"2005","journal-title":"Mol Microbiol"},{"key":"2024110323540060900_dkae320-B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21541264.2023.2293523","article-title":"Targeting bacterial transcription factors for infection control: opportunities and challenges","author":"Al-Tohamy","year":"2024","journal-title":"Transcription"},{"key":"2024110323540060900_dkae320-B42","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1172\/JCI11459","article-title":"Therapeutic applications of transcription factor decoy oligonucleotides","volume":"106","author":"Mann","year":"2000","journal-title":"J Clin Invest"},{"key":"2024110323540060900_dkae320-B43","doi-asserted-by":"publisher","first-page":"102122","DOI":"10.1016\/j.omtn.2024.102122","article-title":"Promising strategies employing nucleic acids as antimicrobial drugs","volume":"35","author":"Moreira","year":"2024","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/11\/2999\/60272325\/dkae320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/11\/2999\/60272325\/dkae320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T23:54:13Z","timestamp":1730678053000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/79\/11\/2999\/7754651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,9,10]]},"published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae320","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,9,10]]}}}